Ixazomib Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 2.3 mg, 3 mg, 4 mg

Reference Brands: Ninlaro® (EU & US)

Category: Oncology Cancer Care

Ixazomib is available in Capsules and strengths such as 2.3 mg, 3 mg, 4 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ixazomib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ixazomib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Ixazomib Capsules, marketed under the brand name Ninlaro®, are a novel oral proteasome inhibitor used in combination therapies for multiple myeloma in patients who have received at least one prior treatment. Ixazomib works by blocking the 20S proteasome, disrupting protein homeostasis in cancer cells and promoting apoptosis. Available in 2.3 mg, 3 mg, and 4 mg capsule strengths, it provides a convenient oral option for patients and physicians. Manufactured under GMP-compliant facilities, Ixazomib is approved in both the US and EU markets, making it an attractive and effective B2B oncology solution for global pharmaceutical supply chains.